Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment

Microbial Pathogenesis

Volumn 55, Issue 1, 2013, Pages 16-20

  Ben Ami, Ronen ^a,e   Watson, Clay C ^b   Lewis, Russell E ^c,d   Albert, Nathaniel D ^b   Arias, Cesar A ^d   Raad, Issam I ^b   Kontoyiannis, Dimitrios P ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Drosophila melanogaster; Methicillin resistant Staphylococcus aureus; Panton Valentine leukocidin; Pulsed field gel electrophoresis; Virulence

Indexed keywords

LINEZOLID; METICILLIN; PANTON VALENTINE LEUKOCIDIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; EXPERIMENTAL MODEL; INNATE IMMUNITY; LETHALITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE; SURVIVAL RATE; TREATMENT RESPONSE; WILD TYPE;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; VIRULENCE;

DROSOPHILA MELANOGASTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84872249064     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.11.012     Document Type: Article

References (28)

1. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
2. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
3. Miller L.G., Perdreau-Remington F., Rieg G., Mehdi S., Perlroth J., Bayer A.S., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445-1453.
4. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
5. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
6. Labandeira-Rey M., Couzon F., Boisset S., Brown E.L., Bes M., Benito Y., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
7. Bubeck Wardenburg J., Palazzolo-Ballance A.M., Otto M., Schneewind O., DeLeo F.R. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008, 198:1166-1170.
8. Hota B., Lyles R., Rim J., Popovich K.J., Rice T., Aroutcheva A., et al. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. Clin Infect Dis 2011, 53:757-765.
9. Peyrani P., Allen M., Wiemken T.L., Haque N.Z., Zervos M.J., Ford K.D., et al. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis 2011, 53:766-771.
10. Campo M., Hachem R., Jiang Y., Dvorak T., Carrillo-Marquez M., Hulten K., et al. Panton valentine leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Medicine (Baltimore) 2011, 90:312-318.
11. Bae I.G., Tonthat G.T., Stryjewski M.E., Rude T.H., Reilly L.F., Barriere S.L., et al. Presence of genes encoding the Panton-Valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009, 47:3952-3957.
12. Voyich J.M., Otto M., Mathema B., Braughton K.R., Whitney A.R., Welty D., et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J Infect Dis 2006, 194:1761-1770.
13. Lemaitre B., Hoffmann J. The host defense of Drosophila melanogaster. Annu Rev Immunol 2007, 25:697-743.
14. Atilano M.L., Yates J., Glittenberg M., Filipe S.R., Ligoxygakis P. Wall teichoic acids of Staphylococcus aureus limit recognition by the Drosophila peptidoglycan recognition protein-SA to promote pathogenicity. PLoS Pathog 2011, 7:e1002421.
15. Ben-Ami R., Lamaris G.A., Lewis R.E., Kontoyiannis D.P. Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis. Med Mycol 2010, 48:310-317.
16. Ghanem G., Hachem R.Y., Chemaly R.F., Dvorak T., Hulten K., Graviss L., et al. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control 2008, 36:656-660.
17. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
18. Martinez-Aguilar G., Avalos-Mishaan A., Hulten K., Hammerman W., Mason E.O., Kaplan S.L. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2004, 23:701-706.
19. Lionakis M.S., Lewis R.E., May G.S., Wiederhold N.P., Albert N.D., Halder G., et al. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. J Infect Dis 2005, 191:1188-1195.
20. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
21. Jones R.N., Nilius A.M., Akinlade B.K., Deshpande L.M., Notario G.F. Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections. Antimicrob Agents Chemother 2007, 51:3381-3384.
22. Bubeck Wardenburg J., Bae T., Otto M., Deleo F.R., Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007, 13:1405-1406.
23. Kobayashi S.D., Malachowa N., Whitney A.R., Braughton K.R., Gardner D.J., Long D., et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011, 204:937-941.
24. Yoong P., Pier G.B. Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun 2012, 80:2894-2904.
25. Dumitrescu O., Boisset S., Badiou C., Bes M., Benito Y., Reverdy M.E., et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 2007, 51:1515-1519.
26. Rubinstein E., Kollef M.H., Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl. 5):S378-S385.
27. Holmes N.E., Turnidge J.D., Munckhof W.J., Robinson J.O., Korman T.M., O'Sullivan M.V., et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011, 204:340-347.
28. Li M., Diep B.A., Villaruz A.E., Braughton K.R., Jiang X., DeLeo F.R., et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 2009, 106:5883-5888.